A detailed history of Act Capital Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 151,100 shares of INMB stock, worth $932,287. This represents 1.29% of its overall portfolio holdings.

Number of Shares
151,100
Previous 160,500 5.86%
Holding current value
$932,287
Previous $1.42 Million 33.97%
% of portfolio
1.29%
Previous 1.98%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$6.04 - $10.44 $56,776 - $98,136
-9,400 Reduced 5.86%
151,100 $937,000
Q2 2022

Aug 12, 2022

SELL
$5.48 - $8.97 $383,600 - $627,900
-70,000 Reduced 30.37%
160,500 $1.42 Million
Q4 2021

Feb 03, 2022

SELL
$9.97 - $20.38 $443,665 - $906,910
-44,500 Reduced 16.18%
230,500 $2.35 Million
Q3 2021

Nov 16, 2021

BUY
$14.13 - $27.85 $3.89 Million - $7.66 Million
275,000 New
275,000 $5.34 Million

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $111M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.